Quarterly Report • Aug 28, 2013
Quarterly Report
Open in ViewerOpens in native device viewer
The condensed interim financial statements as of June 30, 2013 as well as the related explanatory notes have not been subject to a limited review of KPMG Bedrijfsrevisoren.
| In million Euro | June 30, 2013 | Dec. 31, 2012 Restated (1) |
Jan. 1, 2012 Restated (1) |
|---|---|---|---|
| ASSETS | |||
| Non-current assets | 1,099 | 1,156 | 1,221 |
| Intangible assets | 641 | 654 | 681 |
| Property, plant and equipment | 257 | 277 | 301 |
| Investments | 9 | 10 | 15 |
| Deferred tax assets | 192 | 215 | 224 |
| Current assets | 1,653 | 1,674 | 1,728 |
| Inventories | 648 | 635 | 639 |
| Trade receivables | 608 | 636 | 672 |
| Current tax assets | 102 | 97 | 82 |
| Other receivables and other assets | 134 | 149 | 214 |
| Deferred charges | 31 | 27 | 20 |
| Derivative financial instruments | 3 | 3 | 1 |
| Cash and cash equivalents | 127 | 127 | 100 |
| Total assets | 2,752 | 2,830 | 2,949 |
| EQUITY AND LIABILITIES | |||
| Equity | 154 | 169 (1) |
291 |
| Equity attributable to owners of the Company | 114 | 133 (1) |
256 |
| Share capital | 187 | 187 | 187 |
| Share premium | 210 | 210 | 210 |
| Retained Earnings | 631 | 623 (1) |
642 |
| Reserves | (102) | (85) | (90) |
| Translation reserve | (4) | 6 | 11 |
| Post-employment benefits: remeasurements of | |||
| the net defined benefit liability | (808) | (808) (1) |
(704) |
| Non-controlling interests | 40 | 36 | 35 |
| Non-current liabilities | 1,701 | 1,795 | 1,692 |
| Liabilities for post-employment and long-term | |||
| Termination benefit plans | 1,243 | 1,315 (1) |
1,246 |
| Other employment benefits | 12 | 12 | 13 |
| Loans and borrowings | 391 | 410 | 352 |
| Provisions | 13 | 15 | 25 |
| Deferred income | 1 | 1 | 4 |
| Deferred tax liabilities | 41 | 42 | 52 |
| Current liabilities | 897 | 866 | 966 |
| Loans and borrowings | 35 | 8 | 15 |
| Provisions | 185 | 173 | 223 |
| Trade payables | 259 | 278 | 275 |
| Deferred revenue and advance payments | 156 | 138 | 145 |
| Current tax liabilities | 53 | 56 | 47 |
| Other payables | 102 | 109 | 149 |
| Employee benefits | 84 | 99 | 94 |
| Deferred income | 3 | 3 | 4 |
| Derivative financial instruments | 20 | 2 | 14 |
| Total Equity and Liabilities | 2,752 | 2,830 | 2,949 |
(1) During the first half year of 2013, the Group has consistently applied its accounting policies used in the previous year, except for its post-employment benefit plans where the measurement of the defined benefit cost and the net defined benefit liabillty has changed. The changes fully result from the application of the amendments to IAS19 as stated in IAS19 (revised 2011). As such, the net defined benefit liability at January 1, 2013 has increased by 786 million Euro, being 767 million Euro for the Group's material countries and 19 million Euro for the other countries. This impact has been recorded in equity via retained earnings to the extend related to the changes in the determination of the net periodic pension cost for 2012 resulting in an increase of 22 million Euro, the remainder i.e. minus 808 million Euro has been reflected in a separate line item in equity called 'Post-employment benefits: remeasurements of the net defined benefit liability'.
The impact of the changes in accounting policy are also reflected in the restated opening balances at January 1, 2012 and the closing balances at December 31, 2012 as well as in the result over the first half year of 2012. The impact on the closing balances at December 31, 2012 equals the impact at January 1, 2013 which is also reflected in the balances at June 30, 2013 as no recalculation of the net defined benefit liability on June 30, 2013 has taken place. The opening balances at January 1, 2012 comprise remeasurements of the net defined benefit liability amounting to 704 million Euro being 687 million Euro for the Group's material countries and 17 million Euro for the other countries. For the first half year of 2012, other finance expense has been reduced by 13 million Euro being the share of the aforementioned 22 million Euro for the full year 2012 that relates to the first half year of 2012.
| In million Euro | 6 months ending | 6 months ending |
|---|---|---|
| June 30, 2013 | June 30, 2012 | |
| Restated (1 & 2) |
| Revenue | 1,437 | 1,513 | ||
|---|---|---|---|---|
| Cost of sales | (1,023) | (1,079) | ||
| Gross profit | 414 | 434 | ||
| Selling expenses | (186) | (197) | ||
| Research and development expenses | (75) | (86) | ||
| Administrative expenses | (92) | (97) | ||
| Other operating income | 97 | 59 | (1) | |
| Other operating expenses | (79) | (81) | (1) | |
| Result from operating activities | 79 | 32 | ||
| Interest income (expense) – net | (9) | (7) | ||
| Interest income | 1 | 2 | ||
| Interest expense | (10) | (9) | ||
| Other finance income (expense) – net | (28) | (37) | ||
| Other finance income | 3 | 3 | (1) | |
| Other finance expense | (31) | (40) | (1) | (2) |
| Net finance costs | (37) | (44) | (2) | |
| Profit (loss) before income tax | 42 | (12) | (2) | |
| Income tax expense | (31) | (6) | ||
| Profit (loss) for the year | 11 | (18) | (2) | |
| Profit (loss) attributable to: | ||||
| Owners of the Company | 8 | (21) | (2) | |
| Non-controlling interests | 3 | 3 | ||
| Earnings per share | ||||
| Outstanding shares per end of period | 167,751,190 | 167,751,190 | ||
| Weighted number of shares used for calculation | 167,751,190 | 167,751,190 | ||
| Earnings per share (€) | 0.05 | (0.13) | (2) |
| In million Euro | 6 months ending | 6 months ending |
|---|---|---|
| June 30, 2013 | June 30, 2012 | |
| Restated (2) |
| Profit (loss) for the period | 11 | (18) | |
|---|---|---|---|
| Other comprehensive income, net of tax | |||
| Items that may be reclassified subsequently to profit or loss: | |||
| Exchange differences: | (9) | 1 | |
| Exchange differences on translation of foreign operations | (8) | 5 | |
| Exchange differences on net investment hedge | (1) | (3) | |
| Income tax on exchange differences on | |||
| net investment hedge | - | (1) | |
| Cash flow hedges: | (17) | (1) | |
| Effective portion of changes in fair value of | |||
| cash flow hedges | (21) | (7) | |
| Change in fair value of cash flow hedges | |||
| reclassified to profit or loss | 4 | 6 | |
| Income taxes | - | - | |
| Available for sale financial assets: | - | (1) | |
| Changes in the fair value of available-for-sale | |||
| financial assets | - | (1) | |
| Income taxes | - | - | |
| Items that will not be reclassified subsequently to profit or loss: | - | - | |
| Total of other comprehensive income for the period, | |||
| Net of tax | (26) | (1) | |
| Total comprehensive income for the period | (15) | (19) | |
| Attributable to: | |||
| Owners of the Company | (19) | (22) | |
| Non-controlling interests | 4 | 3 |
The statement of comprehensive income for the current interim period (second quarter ending June 30, 2013) with comparative statements of comprehensive income for the comparable interim period for the immediately preceding year, as required by IAS34.20, has been included in addendum.
| In million Euro | 6 months ending June 30, 2013 |
6 months ending June 30, 2012 Restated (1) |
|
|---|---|---|---|
| Profit (loss for the period | 11 | (18) | (1) |
| Adjustments for: | |||
| Depreciation, amortization and impairment losses | 44 | 43 | |
| Changes in fair value of derivative financial instruments | (1) | 2 | |
| Granted subventions | (5) | (4) | |
| (Gains)/losses on sale of non-current assets | (1) | 0 | |
| Net finance costs | 37 | 44 | (1) |
| Income tax expense | 31 | 6 | |
| 116 | 73 | ||
| Changes in: | |||
| Inventories | (20) | (71) | |
| Trade receivables | 20 | 26 | |
| Trade payables | (18) | 15 | |
| Deferred revenue and advance payments | 20 | 23 | |
| Other working capital | (2) | (13) | |
| Non-current provisions | (89) | (46) | |
| Current provisions | (6) | (23) | |
| Cash generated from operating activities | 21 | (16) | |
| Income taxes paid | (6) | (4) | |
| Net cash from (used in) operating activities | 15 | (20) | |
| Interest received | 1 | 1 | |
| Dividends received | 0 | 0 | |
| Proceeds from sale of intangible assets | 1 | 1 | |
| Proceeds from sale of property, plant and equipment | 3 | 2 | |
| Acquisition of intangible assets | (1) | (2) | |
| Acquisition of property, plant and equipment | (15) | (21) | |
| Changes in lease portfolio | 5 | 18 | |
| Change in other investing activities | 0 | 2 | |
| Net cash from (used in) investing activities | (6) | 1 | |
| Interest paid | (14) | (13) | |
| Dividends paid | 0 | 0 | |
| Proceeds from borrowings | 10 | 64 | |
| Repayment of borrowings | 0 | 0 | |
| Other financial flows | (1) | (11) | |
| Net cash from (used in) financing activities | (5) | 40 | |
| Net increase (decrease) in cash and cash equivalents | 4 | 21 | |
| Cash and cash equivalents at 1 January | 125 | 98 | |
| Effect of exchange rate fluctuations | (4) | 4 | |
| Cash and cash equivalents at 30 June | 125 | 123 |
(1) The restatement has been explained under 1.2. 'Consolidated statement of profit or loss and comprehensive income – note (2)'.
| Attributable to owners of the Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| In million Euro | Share Share capital premium |
Retained earnings |
Reserve for own shares |
Revaluation reserve |
Share based payment reserve |
Hedging reserve |
Remeasurement of the net defined benefit liability |
Translation reserve |
Total | Non controlling interests |
Total equity |
|
| Balance at January 1, 2012, as previously reported | 187 | 210 | 642 | (82) | (1) | - (7) |
- | 11 | 960 | 35 | 995 | |
| Impact of change in accounting policy | - | - - |
- | - | - - |
(704) | - | (704) | - | (704) | ||
| Restated balance at January 1, 2012 | 187 | 210 | 642 | (82) | (1) | - (7) |
(704) | 11 | 256 | 35 | 291 | |
| Comprehensive income for the period | ||||||||||||
| Profit (loss) for the period, as restated | - | - (21) |
- | - | - - |
- | - | (21) | 3 | (18) | ||
| Other comprehensive income net of tax, as restated | - | - - |
- | (1) | - (1) |
- | 1 | (1) | - | (1) | ||
| Total comprehensive income for the period | - | - (21) |
- | (1) | - (1) |
- | 1 | (22) | 3 | (19) | ||
| Restated balance at June 30, 2012 | 187 | 210 | 621 | (82) | (2) | - (8) |
(704) | 12 | 234 | 38 | 272 | |
| Balance at January 1, 2013, as previously reported | 187 | 210 | 601 | (82) | (1) | - (2) |
- | 6 | 919 | 36 | 955 | |
| Impact of change in accounting policy | - | - 22 |
- | - | - - |
(808) | - | (786) | - | (786) | ||
| Restated balance at January 1, 2013 | 187 | 210 | 623 | (82) | (1) | - (2) |
(808) | 6 | 133 | 36 | 169 | |
| Comprehensive income for the period | ||||||||||||
| Profit (loss) for the period | - | - 8 |
- | - | - - |
- | - | 8 | 3 | 11 | ||
| Other comprehensive income net of tax | - | - - |
- | - | - (17) |
- | (10) | (27) | 1 | (26) | ||
| Total comprehensive income for the period | - | - 8 |
- | - | - (17) |
- | (10) | (19) | 4 | (15) | ||
| Balance at June 30, 2013 | 187 | 210 | 631 | (82) | (1) | - (19) |
(808) | (4) | 114 | 40 | 154 |
Agfa-Gevaert NV (the "Company") is a company domiciled in Belgium. The condensed interim financial statements of the Company as at and for the six months ended June 30, 2013 comprise the Company and its subsidiaries (together referred to as the "Group") and the Group's interest in associates. The consolidated financial statements of the Group as at and for the year ended December 31, 2012 are available on the Company's website: www.agfa.com.
These condensed consolidated interim financial statements have been prepared in accordance with IAS 34 Interim Financial Reporting as adopted by the European Union. They do not include all of the information required for the full annual financial statements and should be read in conjunction with the consolidated financial statements of the Group as at and for the year ended December 31, 2012. These condensed consolidated interim financial statements were approved by the Board of Directors on August 27, 2013.
The Group has applied in these condensed consolidated interim financial statements the same accounting policies as those applied in the consolidated financial statements as at and for the year ended December 31, 2012 except for the measurement of its post-employment benefit cost and liability. The changes fully result from the application of the amendments to IAS19 as stated in IAS19 (revised 2011).
The condensed consolidated interim financial statements are presented in Euro, rounded to the nearest million.
The preparation of interim financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from estimates.
In preparing the condensed consolidated interim financial statements, the judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those applied to the consolidated financial statements as at and for the year ended December 31, 2012.
An impairment test is to be carried out once a year, and this at the same time, unless indicators would trigger an impairment loss on an earlier moment. The Group performs its impairment test during the fourth quarter. In accordance with IAS 36.12, the comparison of the market capitalization of Agfa-Gevaert per June 30, 2013 with the net asset value of the Company at the same moment is an indicator of a possible impairment, requiring carrying out an impairment test.
Based on IAS 36.99 management decided not to carry out a formal impairment test at June 30, 2013 since the annual impairment test performed at the Cash Generating Unit level had not revealed any impairment loss at December 31, 2012 and since the following criteria were met at June 30, 2013:
| In million Euro | June 30, 2013 | Dec.31, 2012 | January 1, 2012 |
|---|---|---|---|
| Restated | Restated | ||
| Net liability for material countries | 1,108 | 1,169 | 1,091 |
| Net liability for termination | 86 | 95 | 101 |
| benefits | |||
| Net liability for non-material | 49 | 51 | 54 |
| countries | |||
| Total net liability | 1,243 | 1,315 | 1,246 |
For the measurement of its post-employment benefits as at June 30, 2013, the Group has applied in 2013 the amendments to IAS19 as stated in IAS19 (revised 2011) which require the immediate recognition as per January 1, 2013 of the unrecognized actuarial loss as of December 31, 2012. As such, the net defined benefit liability at January 1, 2013 for the material countries has increased by 767 million Euro from 402 million Euro to 1,169 million Euro. For the non-material countries related increase amounted to 19 million Euro (from 32 million Euro to 51 million Euro). The closing balances at December 31, 2012 have been restated for the aforementioned amounts and the impact of this change in accounting policy has also been reflected in the opening balances at January 1, 2012.
The opening balances at January 1, 2012 for the Group's post-employment benefits have been restated by 687 million Euro (from 404 million Euro to 1,091 million Euro) for the material countries and 17 million Euro (from 37 million Euro to 54 million Euro) for the nonmaterial countries.
Because of the amendments to IAS19, the restated net post-employment benefit liability as of December 31, 2012 presents the funded status at that date, comprising for the material countries of defined benefit obligations for 2,192 million Euro and plan assets for a total fair value of 1,023 million Euro.
During the first half year of 2013, the evolution in the carrying amount of the defined benefit obligation for the material countries, being minus 61 million Euro is explained by a net periodic pension cost of 30 million Euro, employer contributions and benefits paid directly by the Company amounting to 36 million Euro and a negative past service cost of 50 million Euro, the remaining difference is explained by translation differences.
In the second quarter of 2013, management has decided to close the post-retirement medical plan in the US, effective as from January 1, 2014, resulting in a negative past service cost of 50 million Euro. This impact has been reported as 'Sundry other operating income' in the consolidated statement of profit or loss for the six months ended June 30, 2013.
As per 30 June 2013, no actuarial calculations have been performed. Given the current financial market evolutions, management assumes an increase of the weighted average discount rate as of June 2013 compared to year-end 2012. The Company expects an improvement of the funded status of its defined benefit plans as at June 30, 2013, substantiated by the evolution of the discount rates combined with the decrease in liability resulting from management's decision to close the medical plan in the US and the fair value of the Group's plan assets that remained stable during the first half year of 2013. Detailed calculations are only performed at year-end. Therefore, in order to understand the Group's sensitivity to the evolution of the discount rates – in general the most decisive factor for the height of the net pension liability – we refer to the Annual Report 2012, disclosure note 20 'Employee Benefits' to the Consolidated Financial Statements.
| In million Euro |
Graphics | HealthCare | Specialty Products |
Total | ||||
|---|---|---|---|---|---|---|---|---|
| 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | |
| Revenue | 751 | 814 | 570 | 578 | 116 | 121 | 1,437 | 1,513 |
| Recurring EBIT (*) |
17 | 20 | 31 | 35 | 11 | 1 | 59 | 56 |
| Segment result (**) |
0 | 8 | 33 | 28 | 11 | (2) | 44 | 34 |
For the six months ended June 30
(*) Recurring EBIT is the result from operating activities before restructuring and nonrecurring items
(**) Segment result is the profit from operating activities
| Consolidated profit (loss) before income taxes | 42 | (12) |
|---|---|---|
| Other finance income (expense) – net | (28) ____ |
(37) (2) ____ |
| Interest income (expense) – net | (9) | (7) |
| Results from operating activities Other unallocated amounts: |
79 | 32 |
| Profit (loss) from operating activities not allocated to a reportable segment |
35 (1) ____ |
(2) ____ |
| Segment result | 44 | 34 |
| In million Euro | 2013 | 2012 Restated |
| For the six months ended June 30 |
(1) The profit from operating activities for the first half year of 2013 that is not allocated to a reportable segment is mainly explained by the impact of the negative past service cost resulting from the closure of the medical plan in the US, to the extend related to the inactive members of the plan (i.e. retirees).
(2) Other finance expense – net for the first half year of 2012 has been restated by 13 million Euro (from 50 million Euro to 37 million Euro) due to the amendments of IAS19 as stated in IAS19 (revised 2011).
For the six months ended June 30
| In million Euro | 2013 | 2012 Restated |
|---|---|---|
| Interest income on bank deposits | 1 | 2 |
| Interest expense | (10) | (9) |
| On bank loans | (3) | (5) |
| On EIB loan | (3) | - |
| On debentures | (4) | (4) |
| Interest income / (expense) – net | ____ (9) |
____ (7) |
| Other finance income | 3 | 3 (3) |
| Other finance expense | (31) | (40) (3) |
| Other finance income / (expense) – net | ____ (28) |
____ (37) |
| Net finance costs | ____ (37) |
____ (44) |
Other finance income / (expense) – net primarily comprise the portion of the net periodic pension cost that is treated as other finance income / (expense) and the interest portion of other interest-bearing provisions. Other finance income / (expense) moreover includes the impact of discounting of assets and liabilities, results on the disposal of marketable securities, changes in fair value of derivative financial instruments that are not part of a hedging relationship and are not linked to operating activities, as well as exchange results on nonoperating activities.
(3) In the course of the third quarter of 2012, the presentation of the exchange results has been changed. The Group offsets its exchange gains and losses per currency to better align with the Group's treasury and hedging policy. As such, other finance income and expense for the first six months of 2012 have both been reduced by 48 million Euro. On top of this change other finance expense over the first half year of 2012 has been reduced by 13 million Euro in order to consider the amendments of IAS19. In total, other finance expense was reduced by 61 million Euro, from 101 million Euro to 40 million Euro.
The condensed interim financial statements as at and for the six months ended June 30, 2013 are affected by the amendments to IAS19 and the recognition of a negative past service cost of 50 million Euro and resulting decrease of 20 million Euro in deferred tax assets. Additionally, the Group booked a restructuring cost amounting to 17 million Euro for the intended closure of the analog printing plate factory in Manerbio, Italy.
Except for the application of IAS19 (revised 2011) and the two aforementioned events, there are no other unusual items that have affected the condensed interim financial statements as at and for the six months ended June 30, 2013.
There were no significant changes in contingencies as those disclosed in the consolidated financial statements of the Group as at and for the year ended December 31, 2012.
For the six months ended June 30, 2013 there are compared to last year no significant changes in the compensation of key management personnel.
As of June 30, 2013 there were no loans outstanding to members of the Executive Management nor to members of the Board of Directors.
Transactions with related companies are mainly trade transactions and are priced at arm's length. The revenue and expenses related to these transactions are immaterial to the condensed consolidated interim financial statements as a whole.
Financial instruments include a broad range of financial assets and liabilities. They include both primary financial instruments such as cash, receivables, debt and shares in another entity and derivative financial instruments. They are measured either at fair value or at amortized cost.
Fair value is the amount for which an asset could be exchanged, or a liability settled between knowledgeable, willing parties in an at arm's length transaction. All derivative financial instruments are recognized at fair value in the statement of financial position.
The fair values of financial assets and liabilities measured at fair value are presented by class in the table below. The Group aggregates its financial instruments into classes based on their nature and characteristics.
| Financial assets and liabilities measured at fair value | ||||||
|---|---|---|---|---|---|---|
| In million Euro | June 30, 2013 | December 31, 2012 | ||||
| Held for | Designated | Available‐ | Held for | Designated | Available‐ | |
| trading | at fair value | for‐sale | trading | at fair value | for‐sale | |
| through | through | |||||
| profit or loss | profit or loss | |||||
| (2) | (1) | (1) | (2) | (1) | (1) | |
| Assets | ||||||
| Financial assets included in investments | ‐ | 2 | 5 | ‐ | 2 | 5 |
| Derivative Financial instruments : | ||||||
| Forward exchange contracts used f | 1 | ‐ | ‐ | 2 | ‐ | ‐ |
| hedging | ||||||
| Other forward exchange contracts | 2 | ‐ | ‐ | 1 | ‐ | ‐ |
| Cash and cash equivalents | ‐ | ‐ | ‐ | ‐ | ‐ | 3 |
| Total Financial assets measured at fair | 3 | 2 | 5 | 3 | 2 | 8 |
| value | ||||||
| Liabilities | ||||||
| Derivative Financial instruments : | ||||||
| Swap contracts used for hedging | 19 | ‐ | ‐ | 1 | ‐ | ‐ |
| Forward exchange contracts used for | ||||||
| hedging | 1 | ‐ | ‐ | ‐ | ‐ | ‐ |
| Other forward exchange contracts | ‐ | ‐ | ‐ | 1 | ‐ | ‐ |
| Total Financial liabilities measured at | 20 | ‐ | ‐ | 2 | ‐ | ‐ |
| fair value |
(1) 'Financial assets designated at fair value through profit or loss' and 'Available-for-sale financial assets' are categorized in their entirety at fair value hierarchy 1 meaning that fair value is determined based on quoted prices in active markets.
(2) Financial assets and liabilities 'Held for trading' are categorized in their entirety at fair value hierarchy 2 meaning that fair value is determined based on inputs other than quoted prices that are observable for the related asset or liability.
Financial instruments other than those listed above are all measured at amortized cost.
For its financial instruments, the Group has applied in its condensed consolidated interim financial statements the same accounting classification and basis for determining fair values as those applied in the consolidated financial statements as at and for the year ended December 31, 2012. Therefore, we refer to the Annual Report 2012, disclosure note 7 'Financial risk management' - 7.5 'Accounting classification and fair values' which comprises more detailed information in this respect.
There are no subsequent events.
Addendum
This information has not been subject to a limited review of KPMG Bedrijfsrevisoren. AGFA-GEVAERT GROUP
| In million Euro | Q2 ending June 30, 2013 |
Q2 ending June 30, 2012 Restated (1 & 2) |
||
|---|---|---|---|---|
| Consolidated statement of profit or loss | ||||
| Revenue | 732 | 779 | ||
| Cost of sales | (521) | (553) | ||
| Gross profit | 211 | 226 | ||
| Selling expenses | (92) | (100) | ||
| Research and development expenses | (36) | (42) | ||
| Administrative expenses | (46) | (49) | ||
| Other operating income | 77 | 30 | (1) | |
| Other operating expenses | (47) | (44) | (1) | |
| Result from operating activities | 67 | 21 | ||
| Interest income (expense) – net | (5) | (3) | ||
| Interest income | - | 1 | ||
| Interest expense | (5) | (4) | ||
| Other finance income (expense) – net | (16) | (17) | ||
| Other finance income | - | 1 | (1) | |
| Other finance expense | (16) | (18) | (1) | |
| Net finance costs | (21) | (20) | ||
| Profit (loss) before income tax | 46 | 1 | ||
| Income tax expense (income) | (23) | 1 | ||
| Profit for the year | 23 | 2 | ||
| Profit attributable to: | ||||
| Owners of the Company | 21 | - | ||
| Non-controlling interests | 2 | 2 |
| In million Euro | Q2 ending June 30, 2013 |
Q2 ending June 30, 2012 Restated (2) |
|
|---|---|---|---|
| Consolidated statement of comprehensive income | |||
| Profit for the period | 23 | 2 | |
| Other comprehensive income, net of tax | |||
| Items that may be reclassified subsequently to profit or loss: | |||
| Exchange differences: | (16) | 6 | |
| Exchange differences on translation of foreign operations | (17) | 12 | |
| Exchange differences on net investment hedge | 2 | (6) | |
| Income tax on exchange differences on | |||
| net investment hedge | (1) | - | |
| Cash flow hedges: | (11) | (3) | |
| Effective portion of changes in fair value of | |||
| cash flow hedges | (14) | (7) | |
| Change in fair value of cash flow hedges | |||
| reclassified to profit or loss | 6 | 3 | |
| Income taxes | (3) | 1 | |
| Available-for-sale financial assets: | - | - | |
| Changes in the fair value of available-for-sale | |||
| financial assets | - | - | |
| Income taxes | - | - | |
| Items that will not be reclassified subsequently to profit or loss: | - | - | |
| Total of other comprehensive income for the period, | |||
| Net of tax | (27) | 3 | |
| Total comprehensive income for the period Attributable to: |
(4) | 5 | |
| Owners of the Company | (5) | 3 | |
| Non-controlling interests | 1 | 2 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.